[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Immunotherapy Drugs Market Research Report 2016

September 2016 | 112 pages | ID: GDC94719EBFEN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Production, means the output of Immunotherapy Drugs

Revenue, means the sales value of Immunotherapy Drugs

This report studies Immunotherapy Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
  • Merck-Pfizer
  • Eli Lilly
  • Amgen
  • Roche
  • Bristol Myers Squibb
  • Dendreon (Valeant)
  • Novartis
  • Seattle Genetics
  • Celgene
  • AstraZeneca
  • Northwest Biotherapeutics
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Immunotherapy Drugs in these regions, from 2011 to 2021 (forecast), like
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
  • Specific Cancer Immunotherapy Drugs
  • Non-Specific Cancer Immunotherapy Drugs
  • Type III
Split by application, this report focuses on consumption, market share and growth rate of Immunotherapy Drugs in each application, can be divided into
  • Leukemia Treatment
  • Colorectal Cancer Treatment
  • Other Cancer Treatment
Global Immunotherapy Drugs Market Research Report 2016

1 IMMUNOTHERAPY DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Immunotherapy Drugs
1.2 Immunotherapy Drugs Segment by Type
  1.2.1 Global Production Market Share of Immunotherapy Drugs by Type in 2015
  1.2.2 Specific Cancer Immunotherapy Drugs
  1.2.3 Non-Specific Cancer Immunotherapy Drugs
  1.2.4 Type III
1.3 Immunotherapy Drugs Segment by Application
  1.3.1 Immunotherapy Drugs Consumption Market Share by Application in 2015
  1.3.2 Leukemia Treatment
  1.3.3 Colorectal Cancer Treatment
  1.3.4 Other Cancer Treatment
1.4 Immunotherapy Drugs Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Immunotherapy Drugs (2011-2021)

2 GLOBAL IMMUNOTHERAPY DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Immunotherapy Drugs Production and Share by Manufacturers (2015 and 2016)
2.2 Global Immunotherapy Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Immunotherapy Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Immunotherapy Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Immunotherapy Drugs Market Competitive Situation and Trends
  2.5.1 Immunotherapy Drugs Market Concentration Rate
  2.5.2 Immunotherapy Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL IMMUNOTHERAPY DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Immunotherapy Drugs Production and Market Share by Region (2011-2016)
3.2 Global Immunotherapy Drugs Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL IMMUNOTHERAPY DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Immunotherapy Drugs Consumption by Regions (2011-2016)
4.2 North America Immunotherapy Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Immunotherapy Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Immunotherapy Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Immunotherapy Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Immunotherapy Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Immunotherapy Drugs Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL IMMUNOTHERAPY DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Immunotherapy Drugs Production and Market Share by Type (2011-2016)
5.2 Global Immunotherapy Drugs Revenue and Market Share by Type (2011-2016)
5.3 Global Immunotherapy Drugs Price by Type (2011-2016)
5.4 Global Immunotherapy Drugs Production Growth by Type (2011-2016)

6 GLOBAL IMMUNOTHERAPY DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Immunotherapy Drugs Consumption and Market Share by Application (2011-2016)
6.2 Global Immunotherapy Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL IMMUNOTHERAPY DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Merck-Pfizer
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Immunotherapy Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Merck-Pfizer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Eli Lilly
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Immunotherapy Drugs Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Eli Lilly Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Amgen
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Immunotherapy Drugs Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Amgen Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Roche
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Immunotherapy Drugs Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Roche Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Bristol Myers Squibb
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Immunotherapy Drugs Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Bristol Myers Squibb Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Dendreon (Valeant)
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Immunotherapy Drugs Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Dendreon (Valeant) Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Novartis
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Immunotherapy Drugs Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Novartis Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Seattle Genetics
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Immunotherapy Drugs Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Seattle Genetics Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Celgene
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Immunotherapy Drugs Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Celgene Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 AstraZeneca
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Immunotherapy Drugs Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 AstraZeneca Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Northwest Biotherapeutics

8 IMMUNOTHERAPY DRUGS MANUFACTURING COST ANALYSIS

8.1 Immunotherapy Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Immunotherapy Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Immunotherapy Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Immunotherapy Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL IMMUNOTHERAPY DRUGS MARKET FORECAST (2016-2021)

12.1 Global Immunotherapy Drugs Production, Revenue Forecast (2016-2021)
12.2 Global Immunotherapy Drugs Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Immunotherapy Drugs Production Forecast by Type (2016-2021)
12.4 Global Immunotherapy Drugs Consumption Forecast by Application (2016-2021)
12.5 Immunotherapy Drugs Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Immunotherapy Drugs
Figure Global Production Market Share of Immunotherapy Drugs by Type in 2015
Figure Product Picture of Specific Cancer Immunotherapy Drugs
Table Major Manufacturers of Specific Cancer Immunotherapy Drugs
Figure Product Picture of Non-Specific Cancer Immunotherapy Drugs
Table Major Manufacturers of Non-Specific Cancer Immunotherapy Drugs
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Immunotherapy Drugs Consumption Market Share by Application in 2015
Figure Leukemia Treatment Examples
Figure Colorectal Cancer Treatment Examples
Figure Other Cancer Treatment Examples
Figure North America Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Immunotherapy Drugs Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Immunotherapy Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Immunotherapy Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Immunotherapy Drugs Production Share by Manufacturers
Figure 2016 Immunotherapy Drugs Production Share by Manufacturers
Table Global Immunotherapy Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Immunotherapy Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Immunotherapy Drugs Revenue Share by Manufacturers
Table 2016 Global Immunotherapy Drugs Revenue Share by Manufacturers
Table Global Market Immunotherapy Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Immunotherapy Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Immunotherapy Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Immunotherapy Drugs Product Type
Figure Immunotherapy Drugs Market Share of Top 3 Manufacturers
Figure Immunotherapy Drugs Market Share of Top 5 Manufacturers
Table Global Immunotherapy Drugs Production by Regions (2011-2016)
Figure Global Immunotherapy Drugs Production and Market Share by Regions (2011-2016)
Figure Global Immunotherapy Drugs Production Market Share by Regions (2011-2016)
Figure 2015 Global Immunotherapy Drugs Production Market Share by Regions
Table Global Immunotherapy Drugs Revenue by Regions (2011-2016)
Table Global Immunotherapy Drugs Revenue Market Share by Regions (2011-2016)
Table 2015 Global Immunotherapy Drugs Revenue Market Share by Regions
Table Global Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table China Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table India Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Immunotherapy Drugs Consumption Market by Regions (2011-2016)
Table Global Immunotherapy Drugs Consumption Market Share by Regions (2011-2016)
Figure Global Immunotherapy Drugs Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Immunotherapy Drugs Consumption Market Share by Regions
Table North America Immunotherapy Drugs Production, Consumption, Import & Export (2011-2016)
Table Europe Immunotherapy Drugs Production, Consumption, Import & Export (2011-2016)
Table China Immunotherapy Drugs Production, Consumption, Import & Export (2011-2016)
Table Japan Immunotherapy Drugs Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Immunotherapy Drugs Production, Consumption, Import & Export (2011-2016)
Table India Immunotherapy Drugs Production, Consumption, Import & Export (2011-2016)
Table Global Immunotherapy Drugs Production by Type (2011-2016)
Table Global Immunotherapy Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Immunotherapy Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Immunotherapy Drugs by Type
Table Global Immunotherapy Drugs Revenue by Type (2011-2016)
Table Global Immunotherapy Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Immunotherapy Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Immunotherapy Drugs by Type
Table Global Immunotherapy Drugs Price by Type (2011-2016)
Figure Global Immunotherapy Drugs Production Growth by Type (2011-2016)
Table Global Immunotherapy Drugs Consumption by Application (2011-2016)
Table Global Immunotherapy Drugs Consumption Market Share by Application (2011-2016)
Figure Global Immunotherapy Drugs Consumption Market Share by Application in 2015
Table Global Immunotherapy Drugs Consumption Growth Rate by Application (2011-2016)
Figure Global Immunotherapy Drugs Consumption Growth Rate by Application (2011-2016)
Table Merck-Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck-Pfizer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck-Pfizer Immunotherapy Drugs Market Share (2011-2016)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Immunotherapy Drugs Market Share (2011-2016)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Immunotherapy Drugs Market Share (2011-2016)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Immunotherapy Drugs Market Share (2011-2016)
Table Bristol Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol Myers Squibb Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol Myers Squibb Immunotherapy Drugs Market Share (2011-2016)
Table Dendreon (Valeant) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dendreon (Valeant) Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Dendreon (Valeant) Immunotherapy Drugs Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Immunotherapy Drugs Market Share (2011-2016)
Table Seattle Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Seattle Genetics Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Seattle Genetics Immunotherapy Drugs Market Share (2011-2016)
Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Celgene Immunotherapy Drugs Market Share (2011-2016)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Immunotherapy Drugs Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immunotherapy Drugs
Figure Manufacturing Process Analysis of Immunotherapy Drugs
Figure Immunotherapy Drugs Industrial Chain Analysis
Table Raw Materials Sources of Immunotherapy Drugs Major Manufacturers in 2015
Table Major Buyers of Immunotherapy Drugs
Table Distributors/Traders List
Figure Global Immunotherapy Drugs Production and Growth Rate Forecast (2016-2021)
Figure Global Immunotherapy Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Immunotherapy Drugs Production Forecast by Regions (2016-2021)
Table Global Immunotherapy Drugs Consumption Forecast by Regions (2016-2021)
Table Global Immunotherapy Drugs Production Forecast by Type (2016-2021)
Table Global Immunotherapy Drugs Consumption Forecast by Application (2016-2021)


More Publications